Medications
EU approves Novartis's advanced breast cancer drug
EU regulators have approved Novartis's new Piqray drug to treat advanced breast cancer, the Swiss pharma giant said Wednesday.
Jul 29, 2020
0
5
News tagged with novartis
Medications
Novartis to pay $336 mn in US settlements on bribes
Novartis agreed to pay around $336 million to settle US charges connected to bribery schemes aimed at increasing sales of its pharmaceutical products, US authorities announced Thursday.
Jun 25, 2020
0
5
Medical research
Novartis holds off on drug price hikes in US amid Trump pressure
Swiss pharmaceutical giant Novartis said Wednesday it would not hike drug prices in the United States this year, following a similar decision by rival Pfizer amid pressure from the White House.
Jul 18, 2018
0
0
Oncology & Cancer
FDA approves CAR T therapy for large B-cell lymphoma
The U.S. Food and Drug Administration (FDA) has expanded approval for a personalized cellular therapy developed at the University of Pennsylvania's Abramson Cancer Center, this time for the treatment of adult patients with ...
May 01, 2018
0
128
Cardiology
Canakinumab reduces risk of cardiovascular events in populations with unmet clinical need
Two new analyses of data from more than 10,000 heart attack survivors worldwide were presented by investigators from Brigham and Women's Hospital at the 2018 American College of Cardiology meeting. Paul Ridker, MD, director ...
Mar 12, 2018
0
1
Diseases, Conditions, Syndromes
Secukinumab effective for moderate / severe scalp psoriasis
(HealthDay)—Secukinumab is safe and effective as a treatment for patients with extensive moderate-to-severe scalp psoriasis, according to a study published in the October issue of the Journal of the American Academy of ...
Sep 29, 2017
0
0
Oncology & Cancer
US clears breakthrough gene therapy for childhood leukemia
Opening a new era in cancer care, U.S. health officials have approved a breakthrough treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia.
Aug 31, 2017
0
124
Oncology & Cancer
'Breakthrough' leukemia drug also portends 'quantum leap' in cost
When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like "breakthrough," "revolutionary" and "a watershed moment."
Aug 24, 2017
0
3
Medications
Greek justice minister vows speedy corruption inquiry
Greece's justice minister on Tuesday promised a "swift and thorough" investigation into suspected corruption by civil servants and Swiss pharmaceutical giant Novartis.
Jan 03, 2017
0
0
Medications
Novartis Korea executives charged for bribing doctors
Prosecutors have indicted the former chief executive of the South Korean unit of Novartis and five other former and current managers over allegations they illegally paid doctors 2.6 billion won ($2.3 million) in return for ...
Aug 13, 2016
0
2
Novartis
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.172 billon in 2008 . Novartis is one of the largest healthcare companies in the world and a leading giant among pharmaceutical companies. Novartis manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. Novartis owns Sandoz, a large manufacturer of generic drugs. The company formerly owned the Gerber Products Company, a major infant and baby products producer, but sold it to Nestlé on 1 September 2007.
Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
This text uses material from Wikipedia, licensed under CC BY-SA
